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ABSTRACT
Objective To compare the effectiveness of two types of
compression treatment (four layer bandage and short
stretch bandage) in people with venous leg ulceration.
Design Systematic review and meta-analysis of patient
level data.
Data sources Electronic databases (the Cochrane Central
Registerof ControlledTrials,the CochraneWounds Group
Specialised Register, Medline, Embase, CINAHL, and
National Research Register) and reference lists of
retrieved articles searched to identify relevant trials and
primary investigators. Primary investigators of eligible
trials were invited to contribute raw data for re-analysis.
Review methods Randomised controlled trials of four
layer bandage compared with short stretch bandage in
people with venous leg ulceration were eligible for
inclusion.Theprimaryoutcomeforthemeta-analysiswas
time to healing. Cox proportional hazards models were
run to compare the methods in terms of time to healing
with adjustment for independent predictors of healing.
Secondary outcomes included incidence and number of
adverse events per patient.
Results Seven eligible trials were identified (887
patients), and patient level data were retrieved for five
(797 patients, 90% of known randomised patients). The
four layer bandage was associated with significantly
shorter time to healing: hazard ratio (95% confidence
interval) from multifactorial model based on five trials
was 1.31 (1.09 to 1.58), P=0.005. Larger ulcer area at
baseline, more chronic ulceration, and previous
ulceration were all independent predictors of delayed
healing. Data from two trials showed no evidence of a
difference in adverse event profiles between the two
bandage types.
Conclusions Venous leg ulcers in patients treated with
fourlayerbandageshealfaster,onaverage,thanthoseof
people treated with the short stretch bandage. Benefits
were consistent across patients with differing prognostic
profiles.
INTRODUCTION
Venouslegulcersareacommonandrecurringchronic
wound caused by damage to the veins and consequent
high venous pressure.
1 The estimated lifetime preva-
lence for leg ulceration in developed countries is 1%
and the point prevalence is 0.1-0.2%. Prevalence
increases with age and is higher among women.
2 The
UK Healthcare Commission has estimated that cur-
rently leg ulcer care costs the NHS £300-600m (€330-
661m,$447-895m)ayear.
3Asubstantialproportionof
the costs is attributable to nursing time.
45These ulcers
are also associated with increased costs and reduced
health related quality of life for patients.
46-8
Compression bandaging is thought to assist ulcer
healing by reducing distension in the leg veins and
accelerating venous blood flow.
1 A previous systema-
tic review of published trial level data concluded that
compression was more effective in healing venous leg
ulcers than no compression, multi-layered systems
were more effective than single layer systems, and
high compression was more effective than low com-
pression, but no clear differences in effectiveness
were detected between different types of high
compression.
9
The four layer bandage and the short stretch ban-
dage are examples of high compression (defined as
ankle sub-bandage pressure 35-40 mm Hg). Such sys-
tems are deemed to deliver the optimum therapeutic
effect in eligible patients but are contraindicated in
people with clinically significant arterial disease. The
four layer bandage (an elastic system), the standard
method in the United Kingdom, comprises orthopae-
dic wool, crepe bandage, elastic bandage, and a final
cohesive retaining layer. All layers are applied from
toes to knee and normally require weekly renewal
but can be changed more often if necessary. The
short stretch system, used as standard treatment in
mainland Europe and Australia, is an inelastic ban-
dage, meaning that it has minimal extensibility (or
“give”) when handled. An orthopaedic wool layer is
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casing around the limb that generates resistance
against calf muscles and other tissues with reapplica-
tion every few days.
1 The short stretch bandage has
the advantage of being washable and reusable.
10 Find-
ings from a large clinical trial of compression treat-
ment, however, indicated that few patients laundered
and reused their short stretch bandages.
w1 The four
layer bandage, commonly available as a proprietary
kit, is designed to be discarded after a single use.
A previous systematic review included two small
trialsthatcomparedfourlayerandshortstretchbanda-
ges.
w2 w3 At the time of the review, the only published
trialleveldataavailableforbothtrialswerethepropor-
tions of ulcers healed at three months, suggesting no
significant differences between the two methods. One
of the trials additionally reported healing rates at one
yearandtimetohealing,withnosignificantdifferences
observed between bandage types.
w3 Estimates of the
frequency of wound healing at fixed time points are
less informative than time to healing as the latter has
major implications for patients’ health related quality
of life and use of health service resources. A further
limitation of the published trial level data was the
inability to investigate subgroups of patients who
might benefit differentially from treatment. We there-
fore carried out a systematic review and meta-analysis
basedonindividualpatientdata tocomparethe effects
of four layer bandage and short stretch bandage on
time to healing of venous leg ulcers, taking account of
prognostic factors. Our methods were based on those
developed by the Cochrane Individual Patient Data
Meta-analysis Methods Group.
11
METHODS
Allmethodswereprespecifiedinthesystematicreview
and meta-analysis protocol (available on request).
Study selection criteria
Randomised controlled trials of four layer bandage
comparedwithshortstretchbandageforthetreatment
of venous leg ulcers were eligible for inclusion.
Identification of trials
InDecember2005wesearchedtheCochraneRegister
of Controlled Trials (CENTRAL) and the Cochrane
Wounds Group Specialised Register with no restric-
tions applied to date, country, or language of publica-
tion. To cover the time lag between studies being
indexed on primary sources and being listed on the
Cochrane databases, we undertook additional
searches for Medline, Embase, and CINAHL (2002-
5). We searched the National Research Register to
identify ongoing trials. All database searches were
updated in March 2008. Figure 1 shows the search
strategy. Initially, search terms were developed for
CENTRALandwereadaptedforuseintheotherdata-
bases.Weexamined the referencelistsofeligibletrials
foradditionalrelevantevaluationsandaskedcollabor-
ating trialists to provide details of any others known to
them.
Two reviewers (SO’M and NC) independently
decided on study selection with disagreements
resolved by discussion.
Data collection and end points
Authorsofeligibletrialswerecontactedinitiallyduring
early 2005 and invited to collaborate in the meta-ana-
lysis. In cases of non-response, reminder messages
were sent, and if necessary these were followed up
with postal and telephone correspondence. We even-
tually established contact with authors of all relevant
trials. We asked trialists to provide anonymised base-
line and outcome data for each randomised patient,
including those excluded from their own analyses, to
maintain randomised groups and to provide as com-
plete a dataset as possible for the meta-analysis. Base-
line data included sex, age, primary or recurrent
ulceration, ulcer duration, ulcer area, ulcer diameter,
appearance of wound bed, ulcer infection, ankle bra-
chial pressure index (ABPI), ankle circumference,
anklemobility,patientmobility,andhistoryofcomor-
bidities such as deep vein thrombosis. Outcome vari-
ables included healing status (that is, healed or not),
date of healing, recurrence status, date of recurrence,
ulcer area at follow-up points during the trial, and
adverse events. In addition, the trialists were asked to
provide date of randomisation, allocated treatment,
date of last follow-up, and details of exclusion from
analysis.Alldataweresystematicallycheckedforcom-
pleteness, duplication, consistency, feasibility, and
integrity of randomisation.
11 Queries were resolved
by discussion with the relevant trialist. Each included
trial was assessed for adequacy of randomised
sequence generation, allocation concealment, and
blinding with methods based on the Cochrane Colla-
boration’s tool for assessing risk of bias in clinical
trials.
12
Total studies identified by search (n=128)
One unpublished study identified after main searches
Studies included in systematic review (n=6)
Unpublished trial could not be included
Studies included in meta-analysis (n=5)
Studies retrieved as full papers for more detailed evaluation
  (n=14)
Principal investigator of unpublished trial contacted and
  details requested
Studies excluded on basis of information
in titles and abstracts (n=114)
Studies excluded from meta-analysis because raw data
irretrievable (n=2) (one of these was unpublished trial)
Studies excluded from systematic review after
  evaluation of full text (n=8):
    Not randomised controlled trial (n=1)
    Ineligible intervention (n=7)
Fig 1 | Search strategy used for CENTRAL
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of randomisation to the date of healing, with healing
defined as complete epithelialisation of the reference
wound. Wounds were examined at least once a week
in all trials. Data for patients with ulcers not healing
within the trial period were censored on the date of
last follow-up. Time to ulcer recurrence was defined
as the time interval between healing and recurrence.
Statistical analysis
The patient was both the sampling unit and the unit of
analysis.
13 In cases where patients had multiple
wounds included in the trial, we selected the largest
for inclusion in the meta-analysis. Analyses were
undertaken on an intention to treat basis (that is,
according to randomised allocation group with inclu-
sion of all patients as the aim). Imputation was not
undertaken for missing data.
The primary outcome was time to healing. To pro-
vide a simple descriptive measure of this outcome, we
performed a preliminary (unadjusted) analysis by gen-
eratingnon-stratifiedKaplan-Meiersurvivalcurvesfor
both treatment groups. The dependent variable was
time to healing in days, the event was a healed ulcer,
and the factor was bandage type.
Next, we generated a Cox proportional hazards
model with time to healing in days as the dependent
variable, healing as the event, and bandage type as a
covariate. This preliminary model did not include
adjustment for baseline characteristics. The main, for-
mal, preplanned analysis entailed a Cox proportional
hazardsmodelasdescribedabovewithadditionalcov-
ariates of sex, age, primary or recurrent ulceration,
ulcer duration, ulcer area, ulcer diameter, appearance
of wound bed, ulcer infection, ankle brachial pressure
index, ankle circumference, ankle mobility, patient’s
mobility, and history of comorbidities—for example,
deep vein thrombosis. Covariates found to be signifi-
cantatthe5%levelinunivariateanalyseswereentered
simultaneously into the model. We then used a back-
ward eliminationmethod to generatehazard ratio esti-
mates of treatment effect. The model was extended to
include tests of statistical interaction between type of
bandage and baseline characteristics. To take account
of any differences in healing rate between study cen-
tres, we entered centres into the model as strata. This
automatically included trial as strata also as no centre
wasin more thanonetrial.To check that stratifyingby
studycentrewasthecorrectapproach,we rantwopre-
liminary Cox models including, firstly, bandage type
and trial and, secondly, bandage type, trial, and centre
as predictors. These models generated identical esti-
mates of treatment effect and so we ran all the above
Cox models stratifying only by study centre.
We carried out checks to assess the proportional
hazards assumption; the linearity of the relation
between the dependent variable and continuous cov-
ariates; whether time to healing was similar during
early and late accrual
14; and adequacy of model fit
with regard to the relation between the number of
events and the number of covariates included in each
model.
15
Togenerateaforest plotshowingtherelativecontri-
bution of each trial to the meta-analysis, we derived
individual trial estimates from the individual patient
data using Cox regression with covariate adjustment
as per the final model as described above. These
hazard ratio estimates were then combined to provide
a visual display of the overall estimate of treatment
effect. This secondary analysis allowed assessment of
heterogeneity between trials, defined with the χ
2 test
(cut off <10% for significance) and the I
2 statistic
(threshold of >50%).
1617
Secondary outcomes included time to ulcer recur-
rence; change in ulcer area at follow-up points during
the trial as a predictor of time to healing; change in
ulcer area during the trial as an outcome of treatment;
andadverseevents.Lackofdatafortherecurrenceand
ulcer area outcomes, however, meant that the planned
analyses could not be undertaken and so these out-
comes are not considered further here.
Adverse events were defined in two ways: as any
adverse event or those considered by the original
investigators to be related to the bandage. For each of
theseoutcomes,we assessedthe effect ofbandagetype
onthe incidenceof adverseevents usingthe odds ratio
with associated 95% confidence intervals. We com-
pared the number of adverse events per patient for
thetwobandagesystemsusingaweightedmeandiffer-
ence with associated 95% confidence intervals. For all
pooled analyses of adverse events, we defined statisti-
cal heterogeneity between individual trial estimates
using the criteria described above. In the absence of
significant heterogeneity, we generated a fixed effect
model, otherwise we planned to use a random effects
model.
Survival analyses were conducted with SPSS (ver-
sion 15.0). The Kaplan-Meier plot was generated with
Stata SE (version 10). Adverse event analyses and for-
est plots were generated with RevMan (version 4.2.8).
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Fig 2 | Kaplan-Meier survival curves (unstratified analysis)
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The search strategy retrieved 128 records of possible
relevance. Of these, six trials were eligible for inclu-
sion.
w1 w2 w3 w4 w5 w6 Four trials were conducted in the
UK
w1 w2 w3 w6andthetwoothersinmainlandEurope.
w4
w5 All trials were individually randomised and
recruited participants with venous leg ulcers (defined
by ankle brachial pressure index ≥0.8 plus clinical his-
tory).Fivetrialsincludedtwotreatmentarmsandcom-
pared the four layer bandage with the short stretch
bandage.
w1 w3 w4 w5 w6Oneofthesehadafactorialdesign
andincludedarandomisedcomparisonoftwotypesof
primary dressing as well as of the two bandage sys-
tems.
w6 Another included an additional treatment
arm that received a two layer paste and support ban-
dage;wecouldnotretrievedataforthistrialbecauseall
records had been destroyed.
w2
We identified an additional eligible unpublished
trial opportunistically during a wound management
conference.Contactwiththeprimaryinvestigatorcon-
firmed that the trial was small (40 patients), had termi-
nated prematurely, and data were no longer available.
The two trials for which data were unavailable
recruited 83 eligible participants overall (9.4% of
known randomised patients). Table 1 shows details
of all eligible trials. Table 2 shows patients’ character-
istics forthe fivetrialswithavailable individualpatient
data (89.8% of known randomised patients) and sug-
gests adequate balance of prognostic factors across
treatment groups for the meta-analysis dataset.
Information gleaned from correspondence with tri-
alists, trial reports, and the individual patient data sug-
gestedthatallfivetrialshaveusedadequatemethodsof
randomisation and allocation concealment. Three
trials used a simple method of randomisation.
w4 w5 w6
Oneofthesewasunstratified,
w5andtwowerestratified
byulcerarea.
w4 w6Allusedsealedenvelopestoconceal
allocation. The fourth trial used blocks of four for ran-
domisation,stratifiedbyulcerarea,andconcealedallo-
cation by using sealed envelopes.
w3 The fifth trial used
permuted blocks stratified by study centre, previous
ulceration, ulcer area, and ulcer duration, and con-
cealed allocation by using a central telephone rando-
misation service.
w1 Checks on the integrity of
randomisation carried out on the individual patient
data suggested that the balance of baseline variables
across groups was satisfactory in each trial.
All five trials defined healing as complete epithelial
cover of the ulcer site with non-blinded assessment by
clinicians.
w1 w3 w4 w5 w6Inthelargesttrial,aninvestigator
blinded to bandage allocation confirmed healing from
photographs at the trial office; this was considered as
an adequate procedure in terms of internal validity.
w1
The characteristics of patients included in this meta-
analysis seemed generally representative of those
undergoing management of venous leg ulcers in out-
patient or community settings.
1819 The proportions of
men and women reflected the relevant epidemiologi-
calevidence,
2andtherewasanadequatespreadofdata
forprognosticbaselinevariablessuchasulcerareaand
ulcerduration.Thedataonanklemobilityandgeneral
mobility suggested that most patients were ambulant.
Reported follow-up periods for trials ranged from
three to 12 months. The overall median follow-up of
patients who did not heal during the trial period was
around 13 weeks (estimate derived from individual
patient data).
Table 1 |Summary of eligible trials on four layer bandage (4LB) compared with short stretch bandage (SSB) (all applied in accordance with manufacturers’
instructions) in people with venous leg ulceration
Study
No (%) of known
randomised
patients
No of study
centres Selection criteria
Median follow-up
(weeks)fornon-healed
patients, derived from
IPD
No patients excluded from
trialists’ analyses/
reinstated for meta-
analysis
Reasons for exclusion
from trialists’ analyses
Unpublished trial
UK
40 (4.5) Unknown Unknown NA Unknown/NA —
Duby et al,
w2 1993,
UK
43 (4.8) 1 Venous leg ulcer; ABPI ≥0.9 NA Unknown/NA —
Scriven et al,
w3 1998, UK 53 (6.0) 1 Venous leg ulceration confirmed
with colour duplex scanning and
ABPI ≥0.8
4LB 13.0, SSB 17.3 4LB 1/0, SSB 2/0 4LB no follow-up data;
SSB 1 no follow-up data,
1 died early in trial
Partsch et al,
w4 2001,
Austria/Netherlands
116 (13.1) 7 New episode of venous leg
ulceration; ulcer aetiology
confirmed by Doppler or clinical
history; ABPI ≥0.8
4LB 7.0, SSB 10.3 Overall 4/0* 3hadnofollow-updata,1
ineligible
Ukat et al,
w5 2003,
Germany
89 (10.0) 2 Venous leg ulceration; ABPI ≥0.8. 4LB 11.9, SSB 12.0 4LB 0/0, SSB 0/0 —
Franks et al,
w6 2004, UK 159 (18.0) 12 Venous leg ulceration; ulcer
aetiology confirmed by clinical
history; ABPI ≥0.8.
4LB 23.7, SSB 23.3 4LB 1/1, SSB 2/2 All 3 ineligible
Iglesias et al,
w1 2004, UK 387 (43.6) 9 Venous leg ulcer ≥1 cm diameter;
ABPI ≥0.8.
4LB 55.0, SSB 54.0 4LB 0/0, SSB 0/0 —
Total 887 (100) 32 — 4LB 13.0, SSB 12.3 Overall 10/3 —
ABPI=ankle brachial pressure index; IPD=individual patient data; NA=not applicable as unable to retrieve individual patient data;
*Breakdown per group not provided.
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errors, such as inconsistent dates, unfeasible values,
and discrepancies between the individual patient data
andthepublishedtrialreport.Thesewereallcorrected
through discussions with the relevant trialists, most
being issues that merely required clarification. Ten
patientswereexcludedfromtheoriginalinvestigators’
own analyses (1.1% of known randomised patients), of
whom three were reinstated for our meta-analysis
(table 1). Data for the seven other patients were not
available from the trialists.
The results of model checking procedures indicated
that the proportional hazards assumption was upheld
for all potentially predictive covariates. The only con-
tinuous covariate included in the final models—base-
line ulcer surface area—was entered as a natural log
transformation. Outcomes were similar for early and
late accruals when we took into account differences
between study centres in four trials assessed.
w1 w4 w5 w6
To assess the adequacy of model fit, we assessed the
numberofevents(thatis,healings)againstthenumber
ofcovariatesenteredatthestartofeachmodel.Atleast
10 events per variable are required in logistic regres-
sion to reduce bias in regression coefficients.
15 All
models generated from the meta-analysis dataset met
this recommendation.
Time to healing
Preliminary analysis
The median time to healing estimated from unstrati-
fied Kaplan-Meier survival analysis of all available
patients (n=797) was 90 days for four layer bandage
and 99 days for the short stretch bandage (fig 2).
Main analysis
AninitialCoxproportionalhazardsmodelbasedonall
five trials (797 patients, 20/797 cases dropped) was
generatedwith time tohealing (days) as the dependent
variable, healing as the event, study centres as strata,
and bandage type as the only covariate. The result of
this unadjusted analysis indicated no significant differ-
ence between bandage types: hazard ratio 1.15, 95%
confidence interval 0.97 to 1.37; P=0.11.
ThenextCoxmodel(fivetrials,797patients,75/797
casesdropped)includedallsignificantcovariatesiden-
tified during univariate analyses: bandage type,
patient’s age, ulcer duration, ulcer area, and ankle
mobility. We used a backward elimination method to
removecovariatesthatbecamenon-significantoneata
time, until the model contained only those making a
significant contribution. The final model contained
typeofbandage,ulcerduration,andulcerarea(table 3).
The hazard ratio for bandage type was 1.31 (1.09 to
1.58; P=0.005), indicating that the estimated probabil-
ity of healing with four layer bandage was around 1.3
times that of healing with the short stretch bandage,
assuming similar values for other covariates. There
was significant evidence that larger ulcers (P<0.001)
and ulcers of longer duration (P<0.001) predicted
longer time to healing independently of one another
and of treatment. The chance of healing was reduced
Table 2 |Characteristics of patients from trials with available individual patient data. Figures
are numbers (percentages) of patients unless stated otherwise
Variable
Four layer bandage
(n=394)
Short stretch bandage
(n=403) Total (n=797)
Sex:
Male 151 (38.3) 166 (41.2) 317 (39.8)
Female 242 (61.4) 237 (58.8) 479 (60.1)
Not recorded 1 (0.3) 0 1 (0.1)
Age (years):
Mean (SD) 69.5 (13.1) 70.3 (13.8) 69.9 (13.5)
Median (range) 71.8 (19-99) 73.0 (23-100) 73.0 (19-100)
Not recorded 0 1 (0.3) 1 (0.1)
Ulcer status:
First 75 (19.0) 86 (21.3) 161 (20.2)
Recurrent 287 (72.8) 286 (71.0) 573 (71.9)
Not recorded 32 (8.1) 31 (7.7) 63 (7.9)
Ulcer duration (months):
≤1 120 (30.5) 122 (30.3) 242 (30.4)
>1-6 157 (39.8) 173 (42.9) 330 (41.4)
>6-12.00 41 (10.4) 40 (9.9) 81 (10.2)
>12 73 (18.5) 60 (14.9) 133 (16.7)
Not recorded 3 (0.8) 8 (2.0) 11 (1.4)
Ulcer area (cm
2):
Mean (SD) 13.7 (36.7) 10.3 (18.8) 12.0 (29.2)
Median (range) 4.3 (0.2-378.3) 4.3 (0.4-143.9) 4.3 (0.2-378.3)
Not recorded 21 (5.3) 27 (6.7) 48 (6.0)
Presence of slough:
Non-sloughy 110 (27.9) 128 (31.8) 238 (29.9)
Sloughy 199 (50.5) 177 (43.9) 376 (47.2)
Not recorded 85 (21.6) 98 (24.3) 183 (23.0)
Presence of granulation:
Non-granulating 122 (31.0) 126 (31.3) 248 (31.1)
Granulating 187 (47.4) 184 (45.7) 371 (46.6)
Not recorded 85 (21.6) 93 (23.1) 178 (22.3)
Presence of epithelialising tissue:
Non-epithelialising 226 (57.4) 221 (54.8) 447 (56.1)
Epithelialising 29 (7.4) 32 (7.9) 61 (7.7)
Not recorded 139 (35.3) 150 (37.2) 289 (36.3)
Ankle brachial pressure index:
Mean (SD) 1.09 (0.18) 1.08 (0.15) 1.08 (0.16)
Median (range) 1.05 (0.76-2.00) 1.06 (0.75-1.70) 1.06 (0.75-2.00)
Not recorded 19 (4.8) 11 (2.7) 30 (3.8)
Ankle circumference:
Mean (SD) 23.9 (2.8) 23.9 (2.8) 23.9 (2.8)
Median (range) 24.0 (16.2-34.0) 24.0 (16.0-33.0) 24.0 (16.0-34.0)
Not recorded 3 (0.8) 6 (1.5) 9 (1.1)
Ankle mobility:
Fully mobile 289 (73.4) 294 (73.0) 583 (73.1)
Impaired 103 (26.1) 104 (25.8) 207 (26.0)
Not recorded 2 (0.5) 5 (1.2) 7 (0.9)
Patient mobility:
Fully mobile 264 (67.0) 265 (65.8) 529 (66.4)
Impaired 103 (26.1) 111 (27.6) 214 (26.9)
Not recorded 27 (6.9) 27 (6.7) 54 (6.8)
History of deep vein thrombosis:
No 147 (37.3) 165 (40.9) 312 (39.1)
Yes 52 (13.2) 46 (11.4) 98 (12.3)
Not recorded 195 (49.5) 192 (47.6) 387 (48.6)
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categorised baseline ulcer duration into ≤1month, >
1-6 months, >6-12 months, and >12 months. The
data suggest that the hazard of healing was reduced
for each step up to a longer duration interval. We
found no significant interactions between bandage
and baseline ulcer area and bandage and ulcer dura-
tion. Figure 3 illustrates the relative contribution of
each trial to the meta-analysis, showing pooled and
individual trial hazard ratio estimates derived from
individual patient data and adjusted for baseline ulcer
area and baseline ulcer duration (heterogeneity
between trials: χ
2 test P=0.11, I
2=47.7%).
We re-ran the analysis on a subset of four trials (747
patients,83/747dropped)forwhichadditionalcovari-
ates were available: primary or recurrent ulceration
and patients’ mobility.
w1 w4 w5 w6 The final model con-
tained bandage type, ulcer area, ulcer duration, and
primary or recurrent ulceration. The estimated hazard
ratio for type of bandage was similar to the model
based on five trials: 1.29, 1.06 to 1.57; P=0.011. The
model suggested that larger ulcers (P<0.001), ulcers
of longer duration (P<0.001), and previous ulceration
(P<0.005) were independent predictors of longer time
to healing (table 4). We found no significant inter-
actions between bandage and baseline ulcer area, ban-
dage and baseline ulcer duration, and bandage and
primary or recurrent ulceration. The level of statistical
heterogeneity between trials did not attain our prespe-
cified level of significance (χ
2 test P=0.11, I
2=50.0%).
Adverse events
Two trials provided data on adverse events.
w1 w6 For
incidence of any type of adverse event, the pooled
oddsratio(fixedeffect)was1.15(95%confidenceinter-
val 0.81 to 1.62; P=0.43) (fig 4), providing no evidence
of a difference between bandage types. The two trials
differedintheirdefinitionsofadverseeventsrelatedto
bandaging.Onetrialcodedeventssuchasmaceration,
allergic reaction, eczema of periulcer skin, and infec-
tion as bandage related.
w1 Another trial, which com-
pared primary dressings as well as bandages,
attributed these events to the former.
w6 In view of this
difference, we did not pool data. We estimated odds
ratios for each trial individually and neither showed a
significant difference between groups: 1.41 (0.94 to
2.11)
w1 and 0.78 (0.30 to 2.04).
w6
Analysis of the number of all types of adverse event
per patient did not show a difference between the two
bandage systems: pooled weighted mean difference
(random effects) 0.21 (95% confidence interval −0.27
to 0.68; P=0.39) (fig 5). Again, we did not pool data for
adverse events related to bandaging for the reasons
mentioned above. We found no significant differences
between groups for the trials individually (0.45 (−0.11
to 1.01)
w1 and −0.04 (−0.17 to 0.09)
w6).
DISCUSSION
When compared with short stretch bandage, the four
layer bandage increases the chance of healing by
around 30% when independent prognostic factors are
takenintoaccount.Thechangeinhazardratioestimate
when we included the prespecified covariates in the
model is to be expected because the covariates are sig-
nificant predictors of time to healing.
20 We therefore
consider that the estimate adjusted for covariates gen-
eratedbythismeta-analysisprovidesthebestunbiased
estimatetodateofthecomparativeeffectsoffourlayer
and short stretch bandages on healing of venous leg
ulcers. Estimates from tests of statistical interaction
indicated that the benefit of four layer bandaging is
consistent across patients with differing prognostic
profiles. The largest trial incorporated a rigorous eco-
nomic analysis and concluded that the four layer sys-
temwasthedominanttreatmentstrategy(thatis,ithad
lower costs with greater health benefits). The cost per
ulcer healed was estimated by taking account of nurse
anddoctorvisits(bothhomeandclinicbased),visitsto
hospital, and costs of bandages and was based on
Kaplan-Meier estimates of time to healing. The mean
(95% confidence interval) annual costs of treatment
were £1298.41 (£1187.83 to £1471.89) for the four
layer bandage and £1525.73 (£1373.92 to £1716.66)
for the short stretch bandage, a difference of £227.32
(£16.53 to £448.30) (costs for year 2001).
w1 Only two
trials provided adequate data on adverse events.
w1 w6
The available data represented 546 out of a total of
887 patients known to be eligible for inclusion in the
meta-analysis (62% of total randomised patients as
shown in table 1).
Findings from our meta analysis are consistent with
those from prognostic studies in suggesting that
  Scrivenw3
  Partschw4
  Ukat
w5
  Franksw6
  Iglesiasw1
Total
1.55 (0.69 to 3.51)
0.71 (0.43 to 1.17)
2.01 (0.83 to 4.91)
1.55 (0.91 to 2.64)
1.42 (1.11 to 1.80)
1.31 (1.09 to 1.58)
5.45
14.47
4.60
12.81
62.67
100.00
0.2 0.5 1 2 5
Study
Favours
short stretch
bandage
Favours
four layer
bandage
Hazard ratio
(fixed effect)
(95% CI)
Hazard ratio
(fixed effect)
(95% CI)
Weight
(%)
23
59
45
84
192
403
Short
stretch
bandage
27
53
44
75
195
394
Four
layer
bandage
No of patients
0.4380 (0.4170)
-0.3470 (0.2560)
0.7000 (0.4540)
0.4390 (0.2720)
0.3490 (0.1230)
Log hazard
ratio (SE)
Fig 3 | Hazard ratio plot for time to healing with pooled and individual estimates adjusted for
baseline ulcer area and ulcer duration
Table 3 |Final model based on five trials. Regression coefficients (β)w i t hs t a n d a r de r r o r s( S E )
and hazard ratios (HR) with 95% confidence intervals
Variable β (SE) HR (95% CI ) P value
Bandage 0.27 (0.10) 1.31 (1.09 to 1.58) 0.005
Duration category (months):
Overall —— <0.001
1.01-6.0 v 0-1 −0.12 (0.11) 0.89 (0.71 to 1.11) 0.293
6.01-12.0 v 0-1 −0.53 (0.19) 0.59 (0.40 to 0.85) 0.005
>12 v 0-1 −1.07 (0.19) 0.35 (0.24 to 0.50) <0.001
Loge ulcer area −0.36 (0.05) 0.70 (0.64 to 0.77) <0.001
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ulceration are independent predictors of time to
healing.
21-23 Although the effectiveness of the short
stretch bandage might be influenced by ankle joint
mobility,
1 we found no significant interaction in our
meta-analysis. This is perhaps unsurprising as most
patientsinthedataset(98%)wereabletowalkunaided
or with assistance. Previous findings have indicated
that the distinction that enables prediction of healing
is fixed versus non-fixed joint.
21
Strengths and weaknesses
Amajorstrengthofthisresearchisthedegreeofrigour.
Ourmethodswere incloseaccordance withthosepro-
posed by the Cochrane Collaboration for conducting
systematic reviews of interventions and the Cochrane
IPD Meta-analysis Methods Group, the latter being a
team who have taken a lead role in developing meth-
ods for meta-analyses based on individual patient
data.
1112
All trials used non-blinded assessment of healing. In
the largest trial, healing was confirmed from photo-
graphs by an investigator blinded to bandage alloca-
tion.
w1 Though it is not possible to define the
direction or degree of bias that might be present in
this meta-analysis from such non-blinded outcome
assessment, the potential for this should not be over-
looked.
All systematic reviews and meta-analyses can be
affected by publication bias.
24 As neither summary
data nor individual patient data were available for the
unpublished trial, and we could not generate a hazard
ratiofortheunavailablepublishedtrial,
w2wecouldnot
judgethepotentialeffectofincludingthesetrialsinthe
meta-analysis. These trials amounted to fewer than
10% of known randomised patients. While the full
dataset is the ideal, the retrieval of around 90% means
that the estimate generated can be viewed with confi-
dence.
The analyses reported in tables 3 and 4 are for fixed
effects models; they treated the effect of type of ban-
dage as constant across the trials. We checked this
assumption by tests of heterogeneity across trials, test-
ing the interaction between type of bandage and trial.
For the data relating to table 3 this gave χ
2=7.03, df=4,
and P=0.13. The corresponding statistics for table 4
datawereχ
2=5.84,df=3,andP=0.12.Forbothanalyses,
this test for heterogeneity reached neither the conven-
tional critical P value of 0.05 nor the more sensitive
critical value of 0.10 sometimes advocated for this
test. We were therefore justified in staying with the
fixed effect model. When the assumption of a fixed
effect is acceptable, introducing random effects might
unnecessarily widen confidence intervals and reduce
power. As a sensitivity analysis, however, we allowed
for a possible random effect of trial by making the trial
a cluster and estimating robust standard errors. This
approach does not change the estimates but does
change their standard errors. For the model in table 3,
the hazard ratio for bandage type was 1.29 (95% con-
fidence interval 1.05 to 1.63; P=0.015) and for table 4
was 1.31 (1.04 to 1.60; P=0.023). Hence, whatever the
approach taken we have evidence of a beneficial effect
of the four layer bandage.
Implications for further research
As far as we can ascertain, this is the first example of
meta-analysis of individual patient data in wound
research. Further such meta-analyses, including both
clinical effectiveness and economic data, could be use-
fully undertaken in the specialty of chronic wound
management given that the main outcome is a time to
event variable: time to healing.
Further clinical trials could assess related outcomes
such as ulcer recurrence and change in ulcer area both
asapredictorandasanoutcome.Inanyfuturetrialthe
area of the ulcer at baseline, the duration of the ulcer,
and whether ulceration is recurrent should be used as
stratification variables at randomisation, or should be
taken into account in the analysis. Primary investiga-
tors should provide detailed records of adverse events
incompressiontrialsandshouldaimtoarriveatacon-
sensus as to the types of adverse events attributable to
the bandage.
The clinical effect of the bandages might in part
depend on the skill of the bandager in achieving the
correct amount of sub-bandage pressure and pressure
graduatedfromtoetoknee.
25Consequently,thediffer-
ential effects of the bandagesseen in thismeta-analysis
couldbepartlyexplainedbyskillandexperienceofthe
bandager; three out of the five included trials (repre-
senting 75% of included patients) were based in the
UK, where the four layer bandage is standard,
w1 w3 w6
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Total
0.80 (0.40 to 1.60)
1.30 (0.87 to 1.93)
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29.77
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Fig 4 | Pooled odds ratio for incidence of any type of adverse event
Table 4 |Final model based on four trials. Regression coefficients (β)w i t hs t a n d a r de r r o r s( S E )
and hazard ratios (HR) with 95% confidence intervals
Variable β (SE) HR (95% CI for HR) P value
Bandage 0.25 (0.10) 1.29 (1.06 to 1.57) 0.011
Duration category (months):
Overall —— <0.001
1.01–6.0 v 0-1 −0.12 (0.12) 0.88 (0.71 to 1.11) 0.281
6.01-12.0 v 0-1 −0.51 (0.20) 0.60 (0.41 to 0.90) 0.013
>12 v 0-1 −1.17 (0.21) 0.31 (0.21 to 0.47) <0.001
Loge ulcer area −0.35 (0.05) 0.70 (0.64 to 0.78) <0.001
Recurrent ulceration −0.45 (0.16) 0.64 (0.47 to 0.87) 0.005
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where the short stretch bandage is standard treat-
ment.
w4 w5 Information regarding bandager skill was
not collected during the included trials and so we
could not investigate this further. As far as we could
ascertain, the methods used for application of both
types of bandage were in line with manufacturers’
recommendations, relevant clinical guidelines, and
expert guidance.
1-27 Future trials could usefully collect
data on staff skills at baseline, and this information
could be included as a covariate in the modelling of
treatment effect.
Implications for clinical practice
Four layer bandaging seems to be more effective than
short stretch bandaging in terms of time to healing.
Patients with larger ulcers, more chronic ulcers, and
recurrent wounds will have longer healing times,
regardless of treatment. The findings are likely to be
generalisable to most patients with venous leg ulcers
who are treated in outpatient clinics or in the commu-
nity.Thechoiceofbandagesystemislikelytobeinflu-
enced by clinician’s preference, skill, or familiarity
withalocallyestablishedregimenandlocalornational
prescribing policies. Other factors influencing the
uptake of a treatment include cost and acceptability
to patients.
Conclusions
Findings suggest that patients with venous leg ulcers
treated with four layer bandages experience faster
healing than those treated with short stretch bandages.
Patients with larger ulcers, older ulcers and recurrent
wounds have poorer healing prognosis regardless of
treatment. These data suggest, however, that the
observed benefits are consistent despite differences in
prognosis. Available data from two trials did not sug-
gestadifferenceintheadverseeventprofilesofthetwo
bandage types. Further research is required on related
outcomes such as ulcer recurrence, change in ulcer
area both as a predictor and as an outcome, and cost
effectiveness. Future trials should incorporate blinded
outcome assessment and, when possible, some assess-
ment of the skill of the bandager at baseline.
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